Keyphrases
Cyclin-dependent Kinase 4 (CDK4)
100%
Immunogenicity
100%
Hepatocellular Carcinoma Cells
100%
T Cell Immunotherapy
100%
Hepatocellular Carcinoma
50%
Palbociclib
50%
Tumor Microenvironment
33%
Doxorubicin
33%
Cellular Senescence
33%
Improved Outcomes
16%
Cancer Cells
16%
Clinical Trials
16%
T Cells
16%
T Cell Immunity
16%
Novel Therapeutics
16%
Novel Mechanism
16%
Cell-Associated
16%
Primary T Cells
16%
Immune Checkpoint
16%
Public Database
16%
Liver Tumor
16%
Hepatocellular Carcinoma Patients
16%
Cell Infiltration
16%
CD8+ T
16%
Immunotherapeutic Approaches
16%
Programmed Death-ligand 1 (PD-L1)
16%
Immune Landscape
16%
Integrated Bioinformatics Analysis
16%
Potential Therapeutic Strategies
16%
Transcriptomic Data
16%
Functional Aspects
16%
Single-cell RNA Sequencing Data
16%
T Cell Cytotoxicity
16%
Mouse Serum
16%
Hepatocellular Carcinoma Model
16%
Tumor Immunogenicity
16%
Senescence-associated Secretory Phenotype
16%
Immunology and Microbiology
Immunotherapy
100%
T Cell
100%
Immunogenicity
100%
Carcinoma Cell
100%
Mouse
40%
Adoptive Immunity
20%
RNA Sequence
20%
Cancer Cell
20%
Upregulation
20%
Cytotoxic T-Cell
20%
Volume
20%
Transcriptome
20%
Cell Infiltration
20%
Immune Landscape
20%
Programmed Death-Ligand 1
20%
T Cell-Mediated Cytotoxicity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Immunotherapy
100%
Immunogenicity
100%
Palbociclib
30%
Malignant Neoplasm
20%
Mouse
20%
Tumor Microenvironment
20%
Doxorubicin
20%
RNA-Sequencing
10%
Clinical Trial
10%
Elimination
10%
Liver Tumor
10%
CD8 Antigen
10%
Transcriptome
10%
T Cell-Mediated Cytotoxicity
10%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Immunogenicity
100%
Mouse
33%
Doxorubicin
33%
Cancer Cell
16%
Upregulation
16%
Clinical Trial
16%
RNA Sequence
16%
Volume
16%
CD8
16%
Cell Infiltration
16%
Cellular Immunity
16%
Immune Checkpoints
16%
Transcriptome
16%
Cell Mediated Cytotoxicity
16%
PD-L1
16%